.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Fuji
Merck
Queensland Health
Julphar
Covington
AstraZeneca
Harvard Business School
Moodys
US Army

Generated: September 26, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: methotrexate

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Antares Pharma Inc
OTREXUP
methotrexate
SOLUTION;SUBCUTANEOUS204824NDAAntares Pharma, Inc.54436-010-011 SYRINGE in 1 CARTON (54436-010-01) > .4 mL in 1 SYRINGE
Antares Pharma Inc
OTREXUP
methotrexate
SOLUTION;SUBCUTANEOUS204824NDAAntares Pharma, Inc.54436-010-044 SYRINGE in 1 CARTON (54436-010-04) > .4 mL in 1 SYRINGE (54436-010-02)
Antares Pharma Inc
OTREXUP
methotrexate
SOLUTION;SUBCUTANEOUS204824NDAAntares Pharma, Inc.54436-012-011 SYRINGE in 1 CARTON (54436-012-01) > .4 mL in 1 SYRINGE
Antares Pharma Inc
OTREXUP
methotrexate
SOLUTION;SUBCUTANEOUS204824NDAAntares Pharma, Inc.54436-012-044 SYRINGE in 1 CARTON (54436-012-04) > .4 mL in 1 SYRINGE (54436-012-02)
Antares Pharma Inc
OTREXUP
methotrexate
SOLUTION;SUBCUTANEOUS204824NDAAntares Pharma, Inc.54436-015-011 SYRINGE in 1 CARTON (54436-015-01) > .4 mL in 1 SYRINGE
Antares Pharma Inc
OTREXUP
methotrexate
SOLUTION;SUBCUTANEOUS204824NDAAntares Pharma, Inc.54436-015-044 SYRINGE in 1 CARTON (54436-015-04) > .4 mL in 1 SYRINGE (54436-015-02)
Antares Pharma Inc
OTREXUP
methotrexate
SOLUTION;SUBCUTANEOUS204824NDAAntares Pharma, Inc.54436-017-011 SYRINGE in 1 CARTON (54436-017-01) > .4 mL in 1 SYRINGE
Antares Pharma Inc
OTREXUP
methotrexate
SOLUTION;SUBCUTANEOUS204824NDAAntares Pharma, Inc.54436-017-044 SYRINGE in 1 CARTON (54436-017-04) > .4 mL in 1 SYRINGE (54436-017-02)
Antares Pharma Inc
OTREXUP
methotrexate
SOLUTION;SUBCUTANEOUS204824NDAAntares Pharma, Inc.54436-020-011 SYRINGE in 1 CARTON (54436-020-01) > .4 mL in 1 SYRINGE
Antares Pharma Inc
OTREXUP
methotrexate
SOLUTION;SUBCUTANEOUS204824NDAAntares Pharma, Inc.54436-020-044 SYRINGE in 1 CARTON (54436-020-04) > .4 mL in 1 SYRINGE (54436-020-02)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Julphar
Covington
Queensland Health
Dow
Moodys
Medtronic
Chinese Patent Office
Express Scripts
Cipla

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot